Summary
First-degree relatives of Type 1 (insulin-dependent) diabetic patients are at increased risk for developing clinical diabetes. The presence of islet cell or insulin autoantibodies further identifies relatives at greater risk, but not all immunologic-marker-positive relatives progress to disease. Beta-cell dysfunction, however, seems to be more prevalent than clinical Type 1 diabetes, since stable subclinical pancreatic Beta-cell dysfunction may occur. Antibodies against a Mr 64,000 (64K) islet Beta-cell protein, identified as glutamic acid decarboxylase, have been reported both at and several years prior to the clinical onset of Type 1 diabetes. We measured 64K antibodies in first-degree relatives with varying degrees of Beta-cell dysfunction and risk for subsequent Type 1 diabetes to determine whether 64K antibodies improve the predictive power of islet cell antibodies and/or insulin autoantibodies. In the Seattle Family Study first-degree relatives of Type 1 diabetic patients are followed prospectively using detailed Beta-cell function tests, insulin sensitivity, quantitative evaluation of islet cell antibodies and fluid phase assay insulin autoantibodies. 64K antibodies were measured using dog islets. Relatives were selected, based on Beta-cell function to represent individuals at high (n=6) and low (n=30) risk for subsequent Type 1 diabetes. The 30 low-risk individuals followed-up for 78 months, had stable Beta-cell function, and six (20%) were negative for all autoantibodies, ten (33%) were positive for insulin autoantibodies, 16 (53%) were islet cell antibody positive while six (20%) were positive for 64K antibodies. In contrast, of the six subjects with progressively declining Beta-cell function who are therefore at high risk, two of whom have already developed Type 1 diabetes, two (33%) were positive for insulin autoantibodies, four (67%) were islet cell antibody positive, while all six (100%) were positive for 64K antibodies. We conclude that antibodies to the Mr 64,000 islet protein correlate with progressive Beta-cell dysfunction more closely than either islet cell antibodies or insulin autoantibodies, but can sometimes be present in individuals whose Beta-cell function remains stable over several years.
Article PDF
Similar content being viewed by others
References
Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Foulis AK, Stewart JA (1984) The pancreas in recent-onset Type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26: 456–461
Klöppel G, Drenck CR, Oberholzer M, Heitz PU (1984) Morphometric evidence for a striking β-cell reduction at the clinical onset of Type 1 diabetes. Virchows Arch Pathol Anat 403: 441–452
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet II: 1279–1283
MacCuish AC, Barnes EW, Irvine WJ, Duncan LJP (1974) Antibodies to pancreatic islet-cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet II: 1529–1531
Lernmark Å, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS (1978) Isletcell-surface antibodies in juvenile diabetes mellitus. N Engl J Med 299: 375–380
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paguette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339
Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298: 167–169
Lendrum R, Walker G, Cudworth AG, Theophanides C, Pyke DA, Bloom A, Gamble DR (1976) Islet-cell antibody in diabetes mellitus. Lancet II: 1273–1276
Gorsuch AN, Dean BM, Bottazzo GF, Lister J, Cudworth AG (1980) Evidence that type 1 diabetes and thyrogastric autoimmunity have different genetic determinants. Br Med J 1: 145–147
Srikanta S, Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP (1986) Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus. Diabetes 35: 139–142
Baekkeskov S, Landin-Olsson M, Kristensen JK et al. (1987) Antibodies to a Mr 64,000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79: 926–934
Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ (1990) 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 335: 1357–1360
Betterle C, Presotto F, Pedini B, Moro L, Slack RS, Zanette F, Zanchetta R (1987) Islet cell and insulin autoantibodies in organspecific autoimmune patients. Their behaviour and predictive value for the development of Type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study. Diabetologia 30: 292–297
Christie M, Landin-Olsson M, Sundkvist G, Dahlquist G, Lernmark Å, Baekkeskov S (1988) Antibodies to a Mr-64000 islet cell protein in Swedish children with newly diagnosed Type 1 (insulin-dependent) diabetes. Diabetologia 31: 597–602
Bärmeier H, McCulloch D, Neifing J, Rajotte R, Palmer J, Lernmark Å (1990) Progression of beta-cell dysfunction is associated with 64K antibodies in first degree relatives of IDDM patients. Diabetes 39 [Suppl 1]: 122A (Abstract)
Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, DeCamilli P (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151–156
Erdö SL, Wolff JR (1990) Gamma-aminobutyric acid outside the mammalian brain. J Neurochem 54: 363–372
Bärmeier H (1990) Species comparison of 64K antigen expression. Immunology of Diabetes, 10th International Workshop. Israel
McCulloch DK, Klaff LJ, Kahn SE et al. (1990) Nonprogression of subclinical β-cell dysfunction among first degree relatives of IDDM patients: 5-yr follow-up of the Seattle family study. Diabetes 39: 549–556
Johnston C, Raghu P, McCulloch D, Beard JC, Ward WK, Klaff LJ, McKight B, Bergman RN, Palmer JP (1987) β-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics. Diabetes 36: 829–837
Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity. Am J Physiol 236: E667-E677
Beard JC, Bergman RN, Ward WK, Porte D Jr (1986) The insulin sensitivity index in non-diabetic man: correlation between clamp derived and IVGTT derived values. Diabetes 35: 362–369
Warnock GL, Rajotte RV (1988) Critical mass of purified islets that induce normaglycaemia after implantation into dogs. Diabetes 37: 467–470
Warnock GL, Cattral MS, Rajotte RV (1988) Normoglycaemia after implantation of purified islet cells in dogs. Can J Surg 31: 421–426
Bordier C (1981) Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256: 1604–1607
Bonifacio E, Lernmark Å, Dawkins RL (1988) Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 106: 83–88
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227: 680–685
Palmer JP, Asplin CM, Raghu PK et al. (1986) Anti-insulin antibodies in insulin-dependent diabetics before insulin treatment — a new marker for autoimmune β-cell damage? Pediatric Adolescent Endocrinol 15: 111–116
Palmer JP, Wilkin TJ, Kurtz AB, Bonifacio E (1990) The Third International Workshop on the Standardization of Insulin Antibody Measurement. Diabetologia 33: 60–61
Wassmuth R, Lernmark Å (1990) The genetics of susceptibility to diabetes. Clinical Immunology Immunopathology 53: 358–399
Barnett AH, Eff C, Leslie RDG, Pyke DA (1981) Diabetes in identical twins: A study of 200 pairs. Diabetologia 20: 87–93
Pyke DA (1988) Development of diabetes in identical twins. Adv Exp Med Biol 246: 255–258
Kumar D, Gemayel NS, Gill SK, Bray GA, Roy-Burman P, Deapen D, Mack TM (1988) Type-specific concordance in young diabetic monozygotic twins. Adv Exp Med Biol 246: 259–267
Ginsberg-Fellner F, Dobersen MJ, Witt ME, Rayfield EJ, Rubenstein P, Notkins AL (1982) HLA antigen, cytoplasmic islet cell antibodies, and carbohydrate tolerance in families of children with insulin-dependent diabetes mellitus. Diabetes 31: 292–297
Tillil H, Köbberling J (1987) Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients. Diabetes 36: 93–99
Tarn AC, Thomas JN, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EAM (1988) Predicting insulin-dependent diabetes. Lancet I: 845–850
Lendrum R, Walker G, Gamble DR (1975) Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet I: 880–883
Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF (1990) Quantification of islet cell antibodies and prediction of insulin dependent diabetes. Lancet 335: 147–149
Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark Å, Sundkvist G (1989) Islet cell and other organ-specific autoantibodies in all children developing Type 1 (insulin-independent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32: 387–395
Dahlquist G, Blom L, Holmgren G, Hägglöf B, Larsson Y, Sterky G, Wall S (1985) The epidemiology of diabetes in Swedish children 0–14 years — A six-year prospective study. Diabetologia 28: 802–808
Group DERI (1990) Secular trends in incidence of childhood IDDM in 10 countries. Diabetes 39: 858–864
Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF (1984) Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes. Lancet I: 764–766
Wilkin T, Armitage M, Casey C, Pyke DA, Hoskins PJ, Rodier M, Diaz JL, Leslie RDG (1985) Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet I: 480–482
Ginsberg-Fellner F, Witt ME, Franklin BH, Yagihashi S, Togushi Y, Dobersen MJ, Rubinstein P, Notkins AL (1985) Triad of markers for identifying children at high risk of developing insulin-dependent diabetes mellitus. JAMA 254: 1469–1470
Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First-degree relatives of patients with Type 1 diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med 313: 462–464
Riley WJ, Maclaren NK, Krischer J et al. (1990) A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167–1172
Christie M, Delovitch TL (1990) Persistence of antibodies to a 64,000-Mr islet cell protein after onset of type 1 diabetes. Diabetes 39: 653–659
Baekkeskov S, Dyrberg T, Lernmark Å (1984) Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 224: 1348–1350
Atkinson MA, Maclaren NK (1988) Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen. Diabetes 37: 1587–1590
Arslanian SA, Becker DJ, Rabin B, Atchinson R, Eberhardt M, Cavender D, Dorman J, Drash AL (1985) Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 34: 926–930
McEvoy RC, Witt ME, Ginsberg-Fellner F, Rubenstein P (1986) Anti-insulin antibodies in children with Type I diabetes mellitus. Diabetes 35: 634–641
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bärmeier, H., McCulloch, D.K., Neifing, J.L. et al. Risk for developing Type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies. Diabetologia 34, 727–733 (1991). https://doi.org/10.1007/BF00401518
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401518